Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 109701-109750 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT03466463
Gene Therapy for Severe Crigler Najjar Syndrome
NA
Recruiting
17 participants
Started: Mar 19, 2018 · Completed: Mar 30, 2030
1 condition
1 sponsor
4 locations
NCT03361436
Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by Surgery
PHASE1
Active, not recruiting
15 participants
Started: Mar 19, 2018 · Completed: Apr 14, 2033
6 conditions
3 sponsors
1 location
NCT03368625
A Study of Neoadjuvant Stereotactic Radiosurgery for Large Brain Metastases
NA
Recruiting
30 participants
Started: Mar 19, 2018 · Completed: Dec 1, 2027
1 condition
1 sponsor
2 locations
NCT03471260
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
PHASE1/PHASE2
Recruiting
96 participants
Started: Mar 19, 2018 · Completed: Sep 30, 2027
6 conditions
1 sponsor
4 locations
NCT03564730
Staged Versus Simultaneous Bilateral Knee Arthroplasty
NA
Active, not recruiting
224 participants
Started: Mar 19, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
8 locations
NCT03458884
Does Cardiorespiratory Interval Training Improve Post-stroke Fatigue
NA
Recruiting
50 participants
Started: Mar 19, 2018 · Completed: Mar 1, 2025
2 conditions
2 sponsors
1 location
NCT03265808
Allogeneic Human Mesenchymal Stem Cell Infusion vs Placebo in Alcohol Use Disorder and Major Depression.
PHASE1/PHASE2
Active, not recruiting
80 participants
Started: Mar 18, 2018 · Completed: Jul 30, 2025
2 conditions
2 sponsors
1 location
NCT04364503
Compliant Analysis of Patient Samples and Data
N/A
Recruiting
2,000 participants
Started: Mar 17, 2018 · Completed: Aug 15, 2030
3 conditions
2 sponsors
1 location
NCT03610451
Floatation-REST and Anorexia Nervosa
NA
Active, not recruiting
68 participants
Started: Mar 16, 2018 · Completed: Oct 31, 2024
1 condition
1 sponsor
1 location
NCT03314636
Intensified Treatment With Carfilzomib in Myeloma Patients Still PET-positive After First Line Treatment.
PHASE2
Active, not recruiting
53 participants
Started: Mar 16, 2018 · Completed: Nov 1, 2026
1 condition
2 sponsors
4 locations
NCT03473795
Developing Non-Communicable Disease Registries in Africa : A Step Towards Providing Quality Data for Improving Patient Outcomes
N/A
Enrolling by invitation
7,566 participants
Started: Mar 16, 2018 · Completed: Mar 31, 2026
1 condition
3 sponsors
14 locations
NCT03220022
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas
PHASE1
Active, not recruiting
46 participants
Started: Mar 16, 2018 · Completed: Jul 16, 2026
4 conditions
1 sponsor
19 locations
NCT03328026
Combination Study of SV-BR-1-GM With Retifanlimab
PHASE1/PHASE2
Enrolling by invitation
36 participants
Started: Mar 16, 2018 · Completed: Nov 30, 2028
4 conditions
2 sponsors
14 locations
NCT03422302
Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
NA
Recruiting
30 participants
Started: Mar 16, 2018 · Completed: May 31, 2028
3 conditions
2 sponsors
1 location
NCT03459846
A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)
PHASE2
Active, not recruiting
154 participants
Started: Mar 16, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
44 locations
NCT03758326
A New Measure of Body Image in Eating Disorders
NA
Active, not recruiting
135 participants
Started: Mar 16, 2018 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT03179540
Non-operative Management for Locally Advanced Rectal Cancer
NA
Recruiting
90 participants
Started: Mar 16, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03476213
Manual Versus Targer-controll Infusion in Reduction of Awareness and Dreaming
NA
Recruiting
80 participants
Started: Mar 16, 2018 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT03483337
New MRI Biomarkers in Head and Neck Cancers
N/A
Recruiting
200 participants
Started: Mar 16, 2018 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT04723654
Evaluating Wearable Smart Sensors for Continuous Measurement of Vital Signs in ICU Patients
N/A
Recruiting
500 participants
Started: Mar 15, 2018 · Completed: Jun 30, 2026
1 condition
1 sponsor
2 locations
NCT03053791
Deep Brain Stimulation in Patients With Incomplete Spinal Cord Injury for Improvement of Gait
NA
Recruiting
5 participants
Started: Mar 15, 2018 · Completed: Dec 31, 2027
1 condition
4 sponsors
1 location
NCT03016156
Determination of the Sensitivity and Specificity of a Smartphone Application to Detect Retinoblastoma
NA
Recruiting
290 participants
Started: Mar 15, 2018 · Completed: Jul 30, 2026
4 conditions
1 sponsor
1 location
NCT03341936
Neodjuvant Nivolumab and Lirilumab, Followed by Surgery, Followed by Adjuvant Nivolumab and Lirilumab, in SCCHN
PHASE2
Active, not recruiting
29 participants
Started: Mar 15, 2018 · Completed: Jul 6, 2026
1 condition
2 sponsors
1 location
NCT03564093
Intranasal Dexmedetomidine Sedation and Analgesia During Pediatric Emergency Room Procedures
PHASE4
Recruiting
112 participants
Started: Mar 15, 2018 · Completed: Jun 10, 2025
2 conditions
1 sponsor
1 location
NCT03425526
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
PHASE1
Recruiting
16 participants
Started: Mar 15, 2018 · Completed: Jan 1, 2027
2 conditions
2 sponsors
1 location
NCT03455868
Bone Health After Bariatric Surgery in Patients With Type 2 Diabetes
N/A
Recruiting
100 participants
Started: Mar 15, 2018 · Completed: Dec 1, 2025
4 conditions
2 sponsors
3 locations
NCT03383094
Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
PHASE2
Active, not recruiting
126 participants
Started: Mar 15, 2018 · Completed: Dec 31, 2027
15 conditions
2 sponsors
6 locations
NCT03510858
Randomized Controlled Trial on Colorectal Cancer Screening Among Quality Circles of Primary Care Physicians
NA
Active, not recruiting
44 participants
Started: Mar 14, 2018 · Completed: Dec 30, 2025
1 condition
2 sponsors
1 location
NCT03432286
A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine
PHASE3
Recruiting
325 participants
Started: Mar 14, 2018 · Completed: Nov 30, 2026
1 condition
1 sponsor
73 locations
NCT03239808
Incremental Haemodialysis in Incident Patients
NA
Active, not recruiting
152 participants
Started: Mar 14, 2018 · Completed: Jun 30, 2025
1 condition
21 sponsors
3 locations
NCT03414970
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer
PHASE3
Active, not recruiting
897 participants
Started: Mar 12, 2018 · Completed: Aug 31, 2035
9 conditions
3 sponsors
859 locations
NCT03257033
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
PHASE3
Recruiting
190 participants
Started: Mar 12, 2018 · Completed: Sep 30, 2026
1 condition
1 sponsor
42 locations
NCT03405779
A New Ultrasonographic Tool to Assess Pulmonary Strain in the ICU
N/A
Recruiting
10 participants
Started: Mar 12, 2018 · Completed: Feb 1, 2026
2 conditions
1 sponsor
1 location
NCT04251143
Dresden Corneal Disease and Treatment Study
N/A
Recruiting
700 participants
Started: Mar 12, 2018 · Completed: Dec 31, 2030
5 conditions
1 sponsor
1 location
NCT03282695
Ozone Therapy in Patients on Waiting List for Surgery Due to Disc Herniation: Prospective, Post-authorization Study
N/A
Active, not recruiting
70 participants
Started: Mar 9, 2018 · Completed: Mar 31, 2026
1 condition
5 sponsors
1 location
NCT03232268
HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid Hemopathies
PHASE1
Active, not recruiting
25 participants
Started: Mar 9, 2018 · Completed: Mar 9, 2027
2 conditions
1 sponsor
1 location
NCT03470467
Posterior Reversible Encephalopathy Syndrome in the Critically Ill Patients
N/A
Recruiting
300 participants
Started: Mar 9, 2018 · Completed: Dec 31, 2028
1 condition
2 sponsors
1 location
NCT03527992
Automated Oxygen Administration in Patients With Hypoxemic Pneumonia and Pleuropneumonia
NA
Recruiting
128 participants
Started: Mar 9, 2018 · Completed: Oct 31, 2028
3 conditions
1 sponsor
1 location
NCT03576742
Severe Immune Cytopenia Registry Www.Sic-reg.Org
N/A
Active, not recruiting
80 participants
Started: Mar 9, 2018 · Completed: Dec 31, 2024
4 conditions
1 sponsor
1 location
NCT03415035
Study Venetoclax Effectiveness and Real-Life Treatment Management in Participants With Chronic Lymphocytic Leukemia
N/A
Active, not recruiting
269 participants
Started: Mar 9, 2018 · Completed: Jun 30, 2026
1 condition
1 sponsor
60 locations
NCT03422822
Study to Evaluate Efficacy and Safety of PF-04965842 With or Without Topical Medications in Subjects Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis
PHASE3
Active, not recruiting
3,166 participants
Started: Mar 8, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
539 locations
NCT03465774
Indwelling Pleural Catheters With or Without Doxycycline in Treating Patients With Malignant Pleural Effusions
N/A
Recruiting
208 participants
Started: Mar 8, 2018 · Completed: Dec 1, 2028
1 condition
2 sponsors
1 location
NCT02825654
Service and Health Among Deployed Veterans
N/A
Enrolling by invitation
6,200 participants
Started: Mar 8, 2018 · Completed: Dec 31, 2027
1 condition
3 sponsors
6 locations
NCT03448835
Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)
PHASE2
Active, not recruiting
20 participants
Started: Mar 7, 2018 · Completed: Oct 31, 2026
2 conditions
2 sponsors
2 locations
NCT03330847
To Assess Safety and Efficacy of Agents Targeting DNA Damage Repair With Olaparib Versus Olaparib Monotherapy.
PHASE2
Active, not recruiting
273 participants
Started: Mar 7, 2018 · Completed: Dec 10, 2025
1 condition
1 sponsor
141 locations
NCT03400137
IOP Elevation Study
NA
Recruiting
150 participants
Started: Mar 7, 2018 · Completed: May 8, 2024
1 condition
2 sponsors
1 location
NCT05954416
FARD (RaDiCo Cohort) (RaDiCo-FARD)
N/A
Recruiting
900 participants
Started: Mar 7, 2018 · Completed: Mar 7, 2027
9 conditions
1 sponsor
15 locations
NCT03465618
A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors
PHASE1
Active, not recruiting
17 participants
Started: Mar 7, 2018 · Completed: Mar 31, 2026
2 conditions
1 sponsor
1 location
NCT05159739
Genetic Susceptibility to Periprosthetic Joint Infections
N/A
Enrolling by invitation
150 participants
Started: Mar 7, 2018 · Completed: Mar 31, 2028
2 conditions
1 sponsor
1 location
NCT03441958
ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
20 participants
Started: Mar 7, 2018 · Completed: Oct 17, 2025
1 condition
3 sponsors
1 location
Previous
1
More pages
2192
2193
2194
2195
2196
2197
2198
More pages
2369
Next